<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25479" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Myoglobinuria</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anwar</surname>
            <given-names>Muhammad Yasir</given-names>
          </name>
          <aff>King Edward Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Yasir Anwar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25479.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Myoglobinuria is the presence of an excess amount of myoglobin in the urine. It is mostly caused by muscle breakdown, releasing a high amount of myoglobin in the blood. Myoglobinuria can lead to acute kidney injury. To avoid the high morbidity and mortality associated with this condition, it must be promptly diagnosed and treated. This activity reviews the evaluation and management of myoglobinuria and highlights the role of the interprofessional team in managing and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of myoglobinuria.</p></list-item><list-item><p>Explain the common physical exam findings associated with myoglobinuria.</p></list-item><list-item><p>Summarize the common complications of myoglobinuria.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve patient outcomes affected by myoglobinuria.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25479&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25479">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25479.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Myoglobin is an iron-containing heme protein that is present predominantly in the sarcoplasm of skeletal and cardiac muscles.<bold>&#x000a0;</bold>Due to the presence of heme moiety, myoglobin serves as a carrier and store for oxygen in muscle cells of the body. Myoglobin has more affinity for oxygen as compared to hemoglobin. As a result, it can acquire oxygen from hemoglobin, hence transferring it from the blood to the muscle tissues.<xref ref-type="bibr" rid="article-25479.r1">[1]</xref></p>
        <p>As the name suggests, myoglobinuria means the presence of an abnormally excessive amount of myoglobin in the urine. As myoglobin is present in the muscle cells, myoglobinuria is almost invariably associated with damage to the cell membranes of myocytes. This breakdown of the muscle cells is also known as rhabdomyolysis. It leads to the release of myoglobin in the blood, from where it is ultimately filtered by the glomerulus and enters the renal tubule.<xref ref-type="bibr" rid="article-25479.r2">[2]</xref></p>
        <p>In this article, we will look into the etiology, pathophysiology, evaluation, management, and complications of myoglobinuria.</p>
      </sec>
      <sec id="article-25479.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>As myoglobin is present in the muscle cells, myoglobinuria is associated with damage to the cell membranes of myocytes. Numerous etiologies can lead to the rupture of the myocytes' cell membranes. They can be categorized broadly into <bold>physical and non-physical </bold>causes.<xref ref-type="bibr" rid="article-25479.r3">[3]</xref></p>
        <p>1. Examples of <bold>physical causes</bold> are trauma, crush injury, heatstroke, hypothermia, malignant hyperthermia, extensive burns, seizures, strenuous exercise, and prolonged immobility.</p>
        <p>2. The <bold>non-physical</bold> causes include hypoxic injury, metabolic disturbances, genetic disorders, infections, drugs, and toxins.</p>
        <list list-type="bullet">
          <list-item>
            <p>Examples of hypoxic injury are carbon monoxide poisoning, vascular thrombosis, and vasculitis.</p>
          </list-item>
          <list-item>
            <p>Metabolic disturbances leading to myoglobinuria include hypokalemia, hypophosphatemia, hyponatremia, hypocalcemia, and hypernatremia.</p>
          </list-item>
          <list-item>
            <p>Genetic disorders leading to muscle cell breakdown include disorders of carbohydrate metabolism (e.g., McArdle disease, phosphofructokinase deficiency), disorders of lipid metabolism (e.g., carnitine deficiency), muscular dystrophy, dermatomyositis, and polymyositis.</p>
          </list-item>
          <list-item>
            <p>Infections mostly causing rhabdomyolysis include coxsackievirus, malaria, herpes virus, influenza virus, HIV, Legionella, and salmonella.</p>
          </list-item>
          <list-item>
            <p>Drugs and toxins which cause rhabdomyolysis are alcohol, sedative-hypnotics, cocaine, methadone, antilipemic drugs, and many others.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25479.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Since myoglobinuria is directly related to muscle injury, it is difficult to assess its stand-alone incidence. However, it is mostly seen in the young population due to more incidences of infection as well as trauma. The athletic population is also much more prone to injuries and rhabdomyolysis, hence the increased incidence of myoglobinuria in that population. Similarly, in the young population, there is an increased incidence of infections leading to myositis, ultimately increasing the cases of myoglobinuria in that population. Rhabdomyolysis and crush syndromes are also common results of natural disasters such as earthquakes, so myoglobinuria is also more commonly seen in the affected population of these disasters.<xref ref-type="bibr" rid="article-25479.r4">[4]</xref><xref ref-type="bibr" rid="article-25479.r5">[5]</xref></p>
      </sec>
      <sec id="article-25479.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Myoglobinuria occurs due to excess myoglobin in the blood resulting from the damage to the cell membrane of myocytes. It can be caused by a direct injury that damages the cells. The intracellular contents, including myoglobin, enters the bloodstream. Alternatively, this damage to the cell membrane can be a result of metabolic disturbances.</p>
        <p>In the case of metabolic factors, the damage to myocytes occurs mostly due to the lack of ATP. Adenosine triphosphate (ATP) is critical to the myocytes, and its levels should be maintained above a certain level to keep the cell viable. The common substrates for ATP production are glycogen and triglycerides. Therefore, any defect in the metabolism of these substrates leads to rhabdomyolysis, especially when the person is involved in ATP requiring activities like strenuous exercise.<xref ref-type="bibr" rid="article-25479.r6">[6]</xref></p>
        <p>In addition to the release of myoglobin, during this process of cell death, the myocytes can accumulate large amounts of fluid, which can lead to hypovolemia as well.</p>
        <p>After cell death, other intracellular contents like creatine kinase (CK), phosphate, and potassium are also released into the blood along with myoglobin, which can lead to electrolyte abnormalities, the most important of which is hyperkalemia as it can lead to cardiac rhythm abnormalities if not corrected appropriately.</p>
        <p>Myoglobin, normally circulating in the blood, is mainly bound to haptoglobin and alpha2- immunoglobulin. However, at levels higher than 0.5 to 1.5 mg/dL, the haptoglobins are saturated, and the excess free myoglobin is filtered by the glomerulus.<xref ref-type="bibr" rid="article-25479.r7">[7]</xref>&#x000a0;</p>
        <p>Although small amounts of myoglobin are normally filtered and quickly excreted by the kidneys, the large amount of myoglobin can damage the kidneys and even cause acute renal failure.<xref ref-type="bibr" rid="article-25479.r8">[8]</xref>&#x000a0;The proposed mechanisms for myoglobin induced nephropathy are:</p>
        <list list-type="order">
          <list-item>
            <p>Renal vasoconstriction as the damaged myocytes sequester fluid and lead to hypovolemia, which activates the renin-angiotensin system leading to renal vasoconstriction.</p>
          </list-item>
          <list-item>
            <p>Heme protein, especially myoglobin, has a direct toxic effect on renal tubules, especially on the proximal tubules.</p>
          </list-item>
          <list-item>
            <p>Excessive myoglobin can interact with Tamm-Horsfall protein in the distal tubules and result in cast formation in the presence of acidic urine. It leads to tubular obstruction.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25479.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The classic history of myoglobinuria points towards rhabdomyolysis and includes the triad of weakness, muscular pain, and dark urine. However, many cases of myoglobinuria present only with dark urine without any other physical symptoms. Patients may complain of some mild non-specific symptoms like tiredness or body aches with dark urine.</p>
        <p>The history of the patient typically includes some pointers towards the cause of rhabdomyolysis like trauma, drug use, strenuous exercise, coma, or some muscle tissue disorder.</p>
        <p>Physical examination may reveal muscle weakness, tenderness, or signs of trauma, but in non-trauma cases, it often is negative. If the muscle tenderness is present, it is usually more prominent in the proximal muscle groups in inflammatory etiologies.</p>
      </sec>
      <sec id="article-25479.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnostic tests typically performed in the case of dark urine starts with a urine dipstick. The urine dipstick test turns out positive for heme in these patients. It is followed by microscopic analysis of the urine, which reveals no red blood cells. This points to the presence of myoglobin in the urine. There are quantitative and more precise tests available to measure myoglobin in the urine, like immunohistochemistry, spectrophotometry, and radioimmunoassay, but they are not commonly required in clinical practice. Creatine kinase levels are also measured, and its high level in blood confirms muscle injury as the cause of myoglobinuria.</p>
        <p>Baseline studies of blood electrolytes and renal function tests are also done as these patients are at increased risk for hyperkalemia and acute kidney injury.</p>
        <p>The patient's medication history should be reviewed to find out if they are taking any medication which is related to rhabdomyolysis.</p>
        <p>Later on, further investigations are carried out to determine the cause of rhabdomyolysis. Some of these investigations include urine toxicology screen, ESR (erythrocyte sedimentation rate) for inflammatory myopathies like dermatomyositis and polymyositis.</p>
      </sec>
      <sec id="article-25479.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The primary goal of treatment in the case of myoglobinuria is to prevent acute kidney injury (AKI), and for that, the initial therapy is mainly focused on rehydration to facilitate the renal clearance of myoglobin. The patient is started on normal saline or Ringer's lactate, and it is titrated to maintain a urine output of 200 to 300 mL/hour.<xref ref-type="bibr" rid="article-25479.r9">[9]</xref>&#x000a0;The electrolyte abnormalities like hyperkalemia are managed using a conservative approach.</p>
        <p>As we know, acidic urine facilitates cast formation; therefore, some specialists recommend alkalinization of urine using intravenous sodium bicarbonate. It is hypothesized to prevent cast formation and crystallization of uric acid.<xref ref-type="bibr" rid="article-25479.r10">[10]</xref></p>
        <p>Similarly, the use of diuretics in such patients is debatable. There is no substantial evidence in favor of their use.<xref ref-type="bibr" rid="article-25479.r11">[11]</xref>&#x000a0;Mannitol and furosemide are sometimes used in some selective patients to prevent non-oliguric renal failure.</p>
        <p>If the patients do not respond to rehydration, hemodialysis is used as a last resort. It removes the nephrotoxic substances as well as corrects the electrolytic abnormalities. There is some evidence that the early initiation of dialysis in patients with rhabdomyolysis may improve the outcome of kidney injury.<xref ref-type="bibr" rid="article-25479.r12">[12]</xref></p>
      </sec>
      <sec id="article-25479.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>There are a few other causes of dark or red-colored or dark urine, also known as pigmenturia. Myoglobinuria should be differentiated from them.<xref ref-type="bibr" rid="article-25479.r13">[13]</xref></p>
        <p>Other causes of pigmenturia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute intermittent porphyria</p>
          </list-item>
          <list-item>
            <p>Hematuria</p>
          </list-item>
          <list-item>
            <p>Hemoglobinuria</p>
          </list-item>
          <list-item>
            <p>Bilirubinuria</p>
          </list-item>
          <list-item>
            <p>Alkaptonuria</p>
          </list-item>
          <list-item>
            <p>Beeturia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25479.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In most cases, the prognosis of myoglobinuria is good. Although it can lead to AKI, most of the time, the damage to the kidney is minimal and reversible.<xref ref-type="bibr" rid="article-25479.r14">[14]</xref></p>
      </sec>
      <sec id="article-25479.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Acute kidney injury (AKI) is the most common complication of myoglobinuria. Studies suggest that up to 50 % of the cases of rhabdomyolysis can cause AKI depending on the cause.<xref ref-type="bibr" rid="article-25479.r15">[15]</xref><xref ref-type="bibr" rid="article-25479.r16">[16]</xref>&#x000a0;Rhabdomyolysis is responsible for approximately 10% of AKI cases.<xref ref-type="bibr" rid="article-25479.r17">[17]</xref><xref ref-type="bibr" rid="article-25479.r18">[18]</xref></p>
        <p>The other most common complication is electrolyte disturbance, especially hyperkalemia due to the spillage of intracellular contents from the damaged myocytes.</p>
      </sec>
      <sec id="article-25479.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>After appropriate management, patients should be educated properly regarding the causes of myoglobinuria. They should be given specific instructions to prevent any such incidence in the future, depending on their respective underlying diagnoses.&#x000a0;</p>
        <p>Firstly, the patients should be educated that it can happen in the future as well. If something like this happens in the future, like they experience dark urine or muscle pain, they should make an appointment with their doctor. Myoglobinuria can be easily checked by a urine sample.</p>
        <p>If the patient is having myoglobinuria due to the prescription medications, they should be given proper education about it, and if possible, the culprit drug should be changed.</p>
        <p>If it has occurred due to rigorous exercise, the patients should be educated to modify their exercise routine and intensity. They should also be advised to maintain proper hydration during their activities.</p>
        <p>And if it is related to some recreational drug use or excessive alcohol consumption, they should be comprehensively counseled about it and should be given proper information about rehabilitation centers if they want to get rid of the use of such substances. They should be given the contact information of such centers as well.&#x000a0;</p>
      </sec>
      <sec id="article-25479.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Myoglobinuria can lead to acute renal failure and can cause permanent damage if not managed appropriately and efficiently. In order to prevent morbidity and mortality, it is best managed by an interprofessional team. It involves the initial management by an emergency physician and a hospitalist so that appropriate earlier hydration can be managed.</p>
        <p>Upon discharge, the patient should be educated about the causes of rhabdomyolysis. College students who present with frequent myoglobinuria due to their athletic activities should be educated about it and may be asked to change their exercise routine and intensity. They should also be advised to hydrate themselves regularly to prevent any renal damage. If the patients are on any prescription medications that can cause muscle breakdown, the pharmacists should also educate the patients about them. They may consult the physician to recommend any alternative drug without any such side effects.</p>
        <p>The main goal is to identify the problem early and maintain communication among the team for early intervention. Early intervention and later on educating the patient about the problem yields the best clinical outcome.<xref ref-type="bibr" rid="article-25479.r19">[19]</xref><xref ref-type="bibr" rid="article-25479.r4">[4]</xref><xref ref-type="bibr" rid="article-25479.r5">[5]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-25479.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25479&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25479">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/myoglobinuria/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25479">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25479/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25479">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25479.s15">
        <title>References</title>
        <ref id="article-25479.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knochel</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and myoglobinuria.</article-title>
            <source>Annu Rev Med</source>
            <year>1982</year>
            <volume>33</volume>
            <fpage>435</fpage>
            <page-range>435-43</page-range>
            <pub-id pub-id-type="pmid">6282181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosch</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Poch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grau</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and acute kidney injury.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Jul</month>
            <day>02</day>
            <volume>361</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-72</page-range>
            <pub-id pub-id-type="pmid">19571284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Myoglobinuria.</article-title>
            <source>Neurol Clin</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>215</fpage>
            <page-range>215-43</page-range>
            <pub-id pub-id-type="pmid">10658177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sever</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Vanholder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lameire</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Management of crush-related injuries after disasters.</article-title>
            <source>N Engl J Med</source>
            <year>2006</year>
            <month>Mar</month>
            <day>09</day>
            <volume>354</volume>
            <issue>10</issue>
            <fpage>1052</fpage>
            <page-range>1052-63</page-range>
            <pub-id pub-id-type="pmid">16525142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunal</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Celiker</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dogukan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ozalp</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kirciman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Simsekli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gunay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Demircin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belhan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yildirim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sever</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>1862</fpage>
            <page-range>1862-7</page-range>
            <pub-id pub-id-type="pmid">15213274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giannoglou</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Chatzizisis</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Misirli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The syndrome of rhabdomyolysis: Pathophysiology and diagnosis.</article-title>
            <source>Eur J Intern Med</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-100</page-range>
            <pub-id pub-id-type="pmid">17338959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slater</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mullins</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review.</article-title>
            <source>J Am Coll Surg</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>186</volume>
            <issue>6</issue>
            <fpage>693</fpage>
            <page-range>693-716</page-range>
            <pub-id pub-id-type="pmid">9632160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin.</article-title>
            <source>Exp Nephrol</source>
            <year>2000</year>
            <season>Mar-Apr</season>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>72</fpage>
            <page-range>72-6</page-range>
            <pub-id pub-id-type="pmid">10729745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scharman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Troutman</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Prevention of kidney injury following rhabdomyolysis: a systematic review.</article-title>
            <source>Ann Pharmacother</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-105</page-range>
            <pub-id pub-id-type="pmid">23324509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shapiro</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Baldea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Luchette</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis in the intensive care unit.</article-title>
            <source>J Intensive Care Med</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>335</fpage>
            <page-range>335-42</page-range>
            <pub-id pub-id-type="pmid">21436168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karajala</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kellum</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Diuretics in acute kidney injury.</article-title>
            <source>Minerva Anestesiol</source>
            <year>2009</year>
            <month>May</month>
            <volume>75</volume>
            <issue>5</issue>
            <fpage>251</fpage>
            <page-range>251-7</page-range>
            <pub-id pub-id-type="pmid">18636060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Splendiani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazzarella</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cipriani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pollicita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Casciani</surname>
                <given-names>CU</given-names>
              </name>
            </person-group>
            <article-title>Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience.</article-title>
            <source>Ren Fail</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>183</fpage>
            <page-range>183-91</page-range>
            <pub-id pub-id-type="pmid">11417950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trujillo</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fragach&#x000e1;n G</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis and Acute Kidney Injury due to Severe Heat Stroke.</article-title>
            <source>Case Rep Crit Care</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>951719</fpage>
            <pub-id pub-id-type="pmid">24826326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodrow</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brownjohn</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Turney</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The clinical and biochemical features of acute renal failure due to rhabdomyolysis.</article-title>
            <source>Ren Fail</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>467</fpage>
            <page-range>467-74</page-range>
            <pub-id pub-id-type="pmid">7569117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chaudhry</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cornblath</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: an evaluation of 475 hospitalized patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>377</fpage>
            <page-range>377-385</page-range>
            <pub-id pub-id-type="pmid">16267412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holt</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and treatment of renal dysfunction in rhabdomyolysis.</article-title>
            <source>Intensive Care Med</source>
            <year>2001</year>
            <month>May</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>803</fpage>
            <page-range>803-11</page-range>
            <pub-id pub-id-type="pmid">11430535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allison</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bedsole</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>The other medical causes of rhabdomyolysis.</article-title>
            <source>Am J Med Sci</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>326</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-88</page-range>
            <pub-id pub-id-type="pmid">12920439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poels</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Gabre&#x000eb;ls</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Rhabdomyolysis: a review of the literature.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-92</page-range>
            <pub-id pub-id-type="pmid">8242960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25479.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ron</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Taitelman</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Michaelson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bar-Joseph</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bursztein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Better</surname>
                <given-names>OS</given-names>
              </name>
            </person-group>
            <article-title>Prevention of acute renal failure in traumatic rhabdomyolysis.</article-title>
            <source>Arch Intern Med</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>144</volume>
            <issue>2</issue>
            <fpage>277</fpage>
            <page-range>277-80</page-range>
            <pub-id pub-id-type="pmid">6696564</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
